Restricted accessResearch articleFirst published online 2002-7
Laryngopharyngeal Reflux: Position Statement of the Committee on Speech,Voice,and Swallowing Disorders of the American Academy of Otolaryngology-Head and Neck Surgery
KoufmanJA.The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): A clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope1991;101(Suppl 53):1–78.
2.
RichterJE, editor. Ambulatory esophageal pH monitoring: practical approach and clinical applications. New York: Igaku-Shoin; 1991.
3.
PostmaGN.Ambulatory pH monitoring methodology. Ann Otol Rhinol Laryngol2000;109(suppl 184):10–4.
OssakowSJEltaGColturiTEsophageal reflux and dysmotility as the basis for persistent cervical symptoms. Ann Otol Rhinol Laryngol1987;96:387–92.
6.
WienerGJKoufmanJAWuWCChronic hoarseness secondary to gastroesophageal reflux disease: Documentation with 24-h ambulatory pH monitoring. Am J Gastroenterol1989;84:1503–8.
7.
PostmaGNTomekMSBelafskyPCEsophageal motor function in laryngopharyngeal reflux is superior to that of classic gastroesophageal reflux disease. Ann Otol Rhinol Laryngol2001;110:1114–6.
8.
AvivJETakoudesTGMaGOffice-based esophagoscopy: A preliminary report. Otolaryngol Head Neck Surg2001;125:170–5.
9.
BelafskyPCPostmaGNKoufmanJA.Transnasal esophagoscopy (TNE). Otolaryngol Head Neck Surg2001;125:588–9.
10.
BainWMHarringtonJWThomasLEHead and neck manifestations of gastroesophageal reflux. Laryngoscope1983;93:175–9.
11.
Al SabbaghGWoJM.Supraesophageal manifestations of gastroesophageal reflux disease. Semin Gastrointest Dis1999;10:113–9.
12.
ToohillRJKuhnJC.Role of refluxed acid in pathogenesis of laryngeal disorders. Am J Med1997;103:100S–6S.
13.
KoufmanJAWienerGJWuWCReflux laryngitis and its sequelae: The diagnostic role of ambulatory 24-hour pH monitoring: J Voice1988;2:78–89.
14.
UlualpSOToohillRJ.Laryngopharyngeal reflux: State of the art diagnosis and treatment. Otolaryngol Clin North Am2000;33:785–01.
15.
KoufmanJA.Contact ulcer and granuloma of the larynx. In GatesG, editor. Current Therapy in Otolaryngology–Head and Neck Surgery. 5th ed.St Louis: Mosby Publishers; 1993. p. 456–9.
16.
HavasTEPriestleyJLowingerDS.A management strategy for vocal process granulomas. Laryngoscope1999;109:301–6.
17.
HansonDGJiangJJ.Diagnosis and management of chronic laryngitis associated with reflux. Am J Med2000;108:112S–9S.
18.
KuhnJToohillRJUlualpSOPharyngeal acid reflux events in patients with vocal cord nodules. Laryngoscope1998;108:1146–9.
19.
RossJANoordzjiJPWooP.Voice disorders in patients with suspected laryngo-pharyngeal reflux disease. J Voice1998;12:84–8.
20.
LittleFBKoufmanJAKohutRIEffect of gastric acid on the pathogenesis of subglottic stenosis. Ann Otol Rhinol Laryngol1985;94:516–9.
21.
WardPHHansonDG.Reflux as an etiological factor of carcinoma of the laryngopharynx. Laryngoscope1988;98:1195–9.
22.
KoufmanJABurkeAJ.The etiology and pathogenesis of laryngeal carcinoma. Otolaryngol Clin North Am1997;30:1–19.
23.
LoughlinCJKoufmanJA.Paroxysmal laryngospasm secondary to gastroesophageal reflux. Laryngoscope1996;106:1502–5.
24.
LoughlinCJKoufmanJAAverillDBAcid-induced laryngospasm in a canine model. Laryngoscope1996;1506–9.
25.
BowreyDJPetersJHDeMeesterTR.Gastroesophageal reflux disease in asthma: Effects of medical and surgical antireflux therapy on asthma control. Ann Surg2000;231:161–72.
26.
HardingSMRichterJEGuzzoMRAsthma and gastroesophageal reflux: Acid suppressive therapy improves asthma outcome. Am J Med1996;100:395–405.
27.
HardingSMRichterJE.The role of gastroesophageal reflux in chronic cough and asthma. Chest1997;111:1389–402.
28.
BothwellMRParsonsDSTalbotAOutcome of reflux therapy on pediatric chronic sinusitis. Otolaryngol Head Neck Surg1999;121:255–62.
29.
RozmanicVMBonifacicM.Gastroesophageal reflux, allergy and chronic tubotympanal disorders in children. Int J Pediatr Otorhinolaryngol2000;55:187–90.
30.
TaskerADettmarPWPanettiMReflux of gastric juice and glue ear in children. Lancet2002;359:493
31.
HalsteadLA.Role of gastroesophageal reflux in pediatric upper airway disorders. Otolaryngol Head Neck Surg1999;120:208–14.
32.
LittleJPMatthewsBLGlockMSExtraesophageal pediatric reflux: 24-hour double-probe pH monitoring of 222 children. Ann Otol Rhinol Laryngol1997;suppl 169:1–16.
33.
WetmoreRF.Effects of acid on the larynx of the maturing rabbit and their possible significance to the sudden infant death syndrome. Laryngoscope1993;103:1242–54.
34.
DukeSGPostmaGNMcGuirtWFJr.Laryngospasm and diaphragmatic arrest in the immature canine after laryngeal acid exposure: A possible model for sudden infant death syndrome (SIDS). Ann Otol Rhinol Laryngol2001;110:729–33.
35.
KoufmanJAAminMRPanettiM.Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg2000;123:385–8.
36.
BelafskyPCPostmaGNKoufmanJA.The validity and reliability of the reflux finding score (RFS). Laryngoscope2001;111:1313–7.
37.
GrontvedAMWestF.pH monitoring in patients with benign voice disorders. Acta Otolaryngol Suppl2000;543:229–31.
38.
JohnsonPEAminMAPostmaGNpH monitoring in patients with laryngopharyngeal reflux (LPR): Why the pharyngeal probe is essential. Otolaryngol Head Neck Surg (in press).
39.
JohnsonPEKoufmanJANowakLJAmbulatory 24-hour double-probe pH monitoring: The importance of manometry. Laryngoscope2001;111:1970–5.
40.
OttDJ.Gastroesophageal reflux disease. Radiol Clin North Am1994;32:1147–66.
41.
Klinkenberg-KnolECMeuwissenSG.Treatment of reflux oesophagitis resistant to H2-receptor antagonists. Digestion1989;suppl 1:47–53.
42.
VigneriSTerminiRLeandroGA comparison of five maintenance therapies for reflux esophagitis. N Engl J Med1995;333:1106–10.
43.
MatonPNOrlandoRJoelssonB.Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease: A prospective, controlled trial. Aliment Pharmacol Ther1999;13:819–26.
44.
JansenJBVan OeneJC.Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group. Aliment Pharmacol Ther1999;13:1611–20.
45.
ScottMGelhotAR.Gastroesophageal reflux disease: Diagnosis and management. Am Fam Physician1999;59:1161–99.
46.
SmithJTGaveyCNwokoloCUTolerance during 8 days of high-dose H2-blockade: Placebo-controlled studies of 24-hour acidity and gastrin. Aliment Pharmacol Ther1990;suppl 1:47–63.
47.
SkoutakisVAJoeRHHaraDS.Comparative role of omeprazole in the treatment of gastroesophageal reflux disease. Ann Pharmacother1995;29:1252–62.
48.
LeiteLPJohnstonBTJustRJPersistent acid secretion during omeprazole therapy: A study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol1996;91:1527–31.
49.
PeghiniPLKatzPOBracyNANocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol1998;93:763–7.
50.
BoughIDJrSataloffRTCastellDOGastroesophageal reflux laryngitis resistant to omeprazole therapy. J Voice1995;9:205–11.
51.
ChivertonSGHowdenCWBurgetDWOmeprazole (20 mg) daily given in the morning or evening: A comparison of effects on gastric acidity, and plasma gastrin and omeprazole concentration. Aliment Pharmacol Ther1992;6:103–11.
52.
KahrilasPJFalkGWJohnsonDAEsomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: A randomized controlled trial. Aliment Pharmacol Ther2000;14:1249–58.
53.
ShawGYSearlJP.Laryngeal manifestations of gastroesophageal reflux before and after treatment with omeprazole. South Med J1997;90:1115–22.
54.
WongRKHansonDGWaringPJENT manifestations of gastroesophageal reflux. Am J Gastroenterol2000;95(suppl 8):515–20.
55.
HardingSMRichterJEGuzzoMRAsthma and gastroesophageal reflux: Acid suppressive therapy improves asthma outcome. Am J Med1995;100:395–05.
56.
AxfordSESharpNRossPECell biology of laryngeal epithelial defenses in health and disease: Preliminary studies. Ann Otol Rhinol Laryngol2001;1099–08.
57.
BelafskyPCPostmaGNKoufmanKA.Laryngopharyngeal reflux symptoms improve before changes in physical findings. Laryngoscope2001;111:979–81.
58.
AvivJELiuHParidesMLaryngopharyngeal sensory deficits in patients with laryngopharyngeal reflux and dysphagia. Ann Otol Rhinol Laryngol2000;109:1000–6.
59.
HunterJ.Laparoscopic fundoplication. Ann Surg1996;223:673–87.
60.
DallemagneBWeertsJMJeahesCResults of laparoscopic Nissen fundoplication. Hepatogastroenterology1998;45:1338–43.